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Methods Immunohistochemical staining Immunohistochemistry (IHC) for desmin, S-100, CK-AE1/AE3, CD34, CD99, Bcl2, vimentin, -smooth muscle actin (-SMA), Ki-67 (all from DAKO Japan, Tokyo, Japan), STAT6 (sc-621; Santa Cruz Biotechnology, Santa Cruz, CA, 1:1000 dilution), NAB2 (sc-23867, Santa Cruz Biotechnology, 1:100 dilution), GRIA2 (ab52896; Abcam, Tokyo, Japan, 1:100 dilution) and PAX8 (10336-1-AP; ProteinTech Group, Chicago, IL, 1:50 dilution) were carried out with a standard procedure, as described elsewhere [25, 32, 36, 37 ]. Briefly, tissue sections (3m) were deparaffinized in xylene, rehydrated.
Endogenous peroxidase was blocked with 3% H2O2 in methanol for 15min.
Sections were incubated with primary antibodies overnight after heatinduced antigen retrieval with a pressure cooker (120°C, 10min). Detection was performed by the peroxidase method using 3,3'-diaminobenzidine in the presence of H2O2. The sections were counterstained with haematoxylin for nuclear detection, dehydrated, and mounted as permanent histological specimens. Appropriate positive and negative controls were used for IHC in 2 the present study.
Identification of a NAB2-STAT6 gene fusion in the SFT sample
Reverse transcription-polymerase chain reaction (RT-PCR) and direct sequencing were used to evaluate the NAB2-STAT6 gene fusion. Briefly, total RNA was extracted from fresh frozen samples using a mirVana miRNA Isolation Kit (Life Technologies Japan, Tokyo, Japan). The first-strand complementary DNA was synthesized from the RNA extracts with a High-Capacity cDNA Reverse Transcription Kit (Life Technologies Japan, Tokyo, Japan).
The NAB2-STAT6 gene fusion was examined via RT-PCR with specifically designed sets of PCR primers, with reference to previous papers [20, 21, 23] . Direct sequence analysis of the PCR products was performed using the Big-Dye terminator method (version 1.1; Applied Biosystems, Foster City, CA) to confirm the breakpoints of fusion transcripts [20, 21, 23] [32]. Primers for RT-PCR and direct DNA sequencing are shown in Table 1 .
In situ proximity ligation brightfield assay
